Friday, April 25, 2025
6.5 C
London
HomeFinTechAtomo Diagnostics: Receives TGA approval for COVID-19 test

Atomo Diagnostics: Receives TGA approval for COVID-19 test

Date:

Revolut’s Karma System: Linking Risky Behavior to Staff Bonuses

How Revolut's innovative approach to compliance is reshaping corporate...

Revolut Ties Employee Bonuses to Risky Behaviors: Implications for Risk Management

Understanding the Impact of Performance Incentives on Corporate Risk...

Nasdaq and AWS Unveil Innovative Capital Markets Infrastructure Blueprint

Transforming Financial Services with Cloud Technology and Advanced SolutionsHighlights:...
  • The approval means that medical professionals in Australia can now use the company’s COVID-19 blood test, AtomoRapid
  • The product will now added to Atomo’s Australian Register of Therapeutic Goods (ARTG) listing, with the HIV Self-Test
  • AtomoRapid jointly manufactured by Atomo and a French company, NG Biotech
  • NG manufactures the test strip, while Atomo manufactures the device
  • Atomo co-founder and Managing Director, John Kelly, pleased with the approval
  • Atomo is up 8.82 per cent on the market this morning and is trading for 37 cents per share

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories